#VisualAbstract: Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...
1. Relugolix was shown to significantly decrease testosterone levels for a sustained period of time in male patients with advanced ...
1. In this retrospective cohort study, fertility preservation proved feasible in transgender feminizing youth, both before and after the initiation ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.